A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 17, 2022

Primary Completion Date

September 16, 2022

Study Completion Date

September 16, 2022

Conditions
Healthy Participants
Interventions
DRUG

PF-07284890 Treatment A

PF-07284890 tablet by mouth while fasting

DRUG

PF-07284890 Treatment B

PF-07284890 tablet after low fat meal

DRUG

PF-07284890 Treatment C

PF-07284890 tablet after high fat meal

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY